bit.bio logo

bit.bio

Website
Current Valuation
N/A
As of December 16, 2024
Total Funding Raised
$214.2M
Last Round
Later Stage VC

$30.0M

Last Funding
Dec 2024

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

bit.bio is currently valued at N/A as of December 16, 2024. The company has raised a total of $214.2M in funding.

Investment Perspective

bit.bio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track bit.bio Valuation Updates

Get notified when bit.bio raises new funding or valuation changes

Explore More Data
Detailed analysis for bit.bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

What is bit.bio Worth in 2025?

As of 2025, bit.bio is valued at N/A, based on the company's Later Stage VC funding round in December 16, 2024. This valuation positions bit.bio as one of the leading private companies in the sector.

bit.bio Valuation History

bit.bio's funding history demonstrates steady growth and investor confidence.

How bit.bio Valuation is Determined

Private company valuations like bit.bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

bit.bio Valuation FAQs

Is bit.bio profitable?

bit.bio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does bit.bio's valuation compare to competitors?

bit.bio is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will bit.bio IPO?

bit.bio has not announced plans for an initial public offering. Until an IPO, investors can access bit.bio shares through secondary market platforms.